$BWXT

BWXT Q3 2026 Earnings Call Transcript

BWXT reported Q3 2026 revenue of $953M, up 10% YoY, with Adjusted EBITDA at $180M and EPS at $1.26. Government Operations saw 22.6% EBITDA margin, while Commercial Operations grew 25%. The company secured contracts for nuclear projects, including the U.S. Army's Janus Program and a Canadian microreactor project. BWXT raised its 2026 free cash flow guidance to $350M-$360M and plans capacity expansions.

Original reporting
Published Nov 3, 2026, 4:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BWXT Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BWXTBullishMed
01

Why it matters

Earnings beat and guidance raise provide fresh material for traders; the stock may react positively in after‑hours trading.

02

Market read

Strong earnings and guidance lift BWXT, with possible spillover to nuclear and defense sectors.

03

What to watch

Potential regulatory delays for advanced nuclear projects and reliance on government contracts.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

BWXT Technologies reported Q3 2026 results, detailing segment performance, new contracts, and raised cash‑flow guidance.

Company-level read

Ticker impact

$BWXTBullishHigh confidence
Context

Q3 2026 earnings call disclosed $953M revenue, 10% YoY growth and raised 2026 free cash flow guidance to $350-$360M.

Expected impact

likely upward pressure as market prices in stronger revenue and cash flow outlook

Evidence & confidence

Revenue beat and guidance raise are material new information; investors may bid the stock higher.

Market effects

Highlights strength in the nuclear services and advanced reactor segment, may boost related defense and energy stocks.

U.S. nuclear and defense contractors could see modest interest.

Shows continued demand for nuclear microreactors internationally, supporting broader clean‑energy narratives.

Counterpoint

If guidance is overly optimistic, execution risk could lead to disappointment on future quarters.

Key entities

  • BWXT Technologies

    U.S. nuclear services and advanced reactor provider.

Related articles

$BWXTMedAI 8/10

BWX Technologies Q3 Earnings Call Highlights

BWX Technologies reported Q3 highlights, including a $189M fuel contract and revenue growth in special materials. The company is advancing nuclear projects, such as a high-enriched uranium facility and a large-scale HPDU plant. BWXT also secured awards for its advanced nuclear reactors and raised its 2026 free-cash-flow outlook to $350M-$360M, maintaining adjusted EBITDA and EPS guidance.

$BWXTMed

BWX (NYSE:BWXT) misses Q3 2026 sales expectations

BWX reported Q3 2026 revenue of $953M, missing estimates by 2.1% but beating EPS expectations. Adjusted EBITDA and free cash flow margins improved. Management maintained full-year EPS guidance at $4.74 and raised EBITDA guidance. Backlog grew 15.6% year-on-year to $8.56B.